BK polyomavirus (BKPyV) remains a significant challenge after kidney transplantation.
International experts reviewed current evidence and updated recommendations according …

The BK polyomavirus (BKPyV), a representative of the family Polyomaviridae, is widespread
in the human population. While the virus does not cause significant clinical symptoms in …

BK polyomavirus (BKPyV) is a human DNA virus that resides latent in the host's renal tissue.
Reactivation occurs occasionally and in case of kidney transplantation, it can lead to …

BK polyomavirus (BKPyV) is an opportunistic pathogen that uses the b-series gangliosides
GD1b and GT1b as entry receptors. Here, we characterize the impact of naturally occurring …

Abstract In 2019, there were about 100,000 kidney transplants globally, with more than a
quarter of them performed in the United States. Unfortunately, some engrafted organs are …

Merkel cell polyomavirus (MCPyV) viral protein 1 (VP1) is the capsid protein that mediates
virus attachment to host cell receptors and is the major immune target. Given the limited data …

Mutations in the BK polyomavirus (BKPyV) capsid accumulate in kidney transplant (KTx)
recipients with persistent virus replication. They are associated with neutralization escape …

Polyomaviruses are ubiquitous human pathogens that cause lifelong, asymptomatic
infections in healthy individuals. Although these viruses are restrained by an intact immune …

ABSTRACT BK polyomavirus (BKPyV) is a double-stranded DNA virus causing
nephropathy, hemorrhagic cystitis, and urothelial cancer in transplant patients. The BKPyV …

Renal transplantation is one of the primary approaches for curing end-stage kidney disease.
With advancements in immunosuppressive agents, the short-term and long-term survival …